According to the National electronic Library for Medicines, lansoprazole suspension (Zoton®) is to be discontinued.
The place in therapy for the suspension formulation has always been limited to patients who struggled to swallow a solid dosage form like a tablet or a capsule. The FasTab® formulation of lansoprazole would appear to be a cost-effective and suitable alternative. The Drug Tariff for August 2007 lists current prices as follows:
- Lansoprazole 30mg orodispersible tablets (28) - £11.00
- Lansoprazole 30mg gastro-resistant granules sachets (8) - £33.97
Action: Clinicians should be aware of this product discontinuation and ensure prescriptions are altered to a suitable alternative before supply issues arise.
|« MeReC Bulletin - Rheumatoid Arthritis||Alzheimer's review completed »|